Tag Archives: diabetes

Poor Diet Causes 70% of Type 2 Diabetes, Says New Study – Medscape

  1. Poor Diet Causes 70% of Type 2 Diabetes, Says New Study Medscape
  2. Type 2 Diabetes Rates Rise Globally Due to Refined Carbs and Processed Meats Everyday Health
  3. Diabetes alert in Rapid City. Doctor Explains | State | newscenter1.tv Newscenter1.tv
  4. These 3 Eating Habits Could Increase Your Risk for Diabetes, According to New Research EatingWell
  5. Trends in dietary patterns over the last decade and their association with long-term mortality in general US populations with undiagnosed and diagnosed diabetes | Nutrition & Diabetes Nature.com
  6. View Full Coverage on Google News

Read original article here

‘Mike & Molly’ star Billy Gardell details 150-pound weight loss: My diabetes is ‘gone’ – Page Six

  1. ‘Mike & Molly’ star Billy Gardell details 150-pound weight loss: My diabetes is ‘gone’ Page Six
  2. Billy Gardell Gives Update on His 150-Pound Weight Loss PEOPLE
  3. Billy Gardell Gives an Update on His 150-Pound Weight Loss and Reveals How Much He Weighs Today (Exclusive) Entertainment Tonight
  4. ‘Bob Hearts Abishola’ Star Billy Gardell Shows Off Impressive 150 Pound Weight loss HollywoodLife
  5. Bob Hearts Abishola’s Billy Gardell Updates Fan On His Health & Weight Loss Journey | Billy Gardell Just Jared
  6. View Full Coverage on Google News

Read original article here

Ozempic And Wegovy: What To Know About Semaglutide Weight Loss Drugs

A new class of weight loss drugs on the market have been making waves since they were authorized as a treatment for obesity in 2021. Semaglutide injections, which you may know as Wegovy or Ozempic, have become wildly popular over the past several months, thanks to the buzz they’ve received from TikTok influencers (and rumors of use among some celebrities).

The prescription injections were introduced as a diabetes treatment in 2017, but people soon realized that the medications — which help people with diabetes to manage their blood sugar levels — also led to significant weight loss in people with obesity who’d struggled to lose weight with other treatments.

From there, interest in the drugs grew, and after clinical trials confirmed what people suspected — that semaglutide injections help people lose weight — demand soared, so much so that pharmacies across the country are experiencing shortages in both Wegovy and Ozempic. Obesity specialists understand the hype; this kind of prescription weight loss medication has been a long time coming.

“For those of us who treat obesity, this is a game-changer we’ve never seen before,” said Dr. Dan Azagury, a bariatric surgeon at Stanford Health Care. “This is the first time ever that we have really effective drugs to treat obesity.”

Obesity is one of the most common chronic health conditions in the United States, but until recently, we haven’t had very effective drugs to address the health complications it’s commonly linked to, such as high cholesterol and high blood pressure. Aside from lifestyle changes like diet and exercise, the go-to intervention for obesity has been surgery (think: gastric bypass or the duodenal switch).

According to Azagury, many obesity specialists noticed that, in the wake of receiving bariatric surgery, many patients were suddenly no longer diabetic. Upon investigating the reason for this, researchers identified new gut hormones, including one called glucagon-like peptide (GLP-1), that reacted to food going into the gut.

Further testing revealed that GLP-1, which increases after bariatric surgery, improves blood sugar levels, and consequently helps with diabetes. “That’s why major diabetes goes away within days of surgery,” Azagury said.

After this discovery, pharmaceutical companies set out to form a diabetes drug that could activate those GLP-1 receptors. That’s what led to the development of semaglutidea synthetic compound that mimics the effects of GLP-1 ― and later the semaglutide-based diabetes drug Ozempic, which got approval from the Food and Drug Administration in 2017.

The other key finding about GLP-1: It slows down digestion and reduces food intake, according to Dr. Janelle Duah, a Yale Medicine internist. This is why Ozempic, which is intended for diabetes, has been and continues to be prescribed off-label for weight loss, Azagury said.

The weight loss effects of GLP-1 (which are revved up through semaglutide), combined with the wild demand for Ozempic, drove the drug manufacturer, Novo Nordisk, to create a very similar drug specifically for weight loss: Wegovy. Essentially just a stronger dosage of Ozempic, Wegovy got FDA approval in June 2021.

Who’s a candidate for the medications?

Wegovy, a once-a-week shot, is for adults who have a body mass index over 30, or who have a BMI above 27 with at least one weight-related health issue (think: high blood pressure, diabetes or high cholesterol). It’s also meant to supplement physical activity and dietary changes, which is why obesity specialists like Azagury recommend that patients work with a comprehensive team of providers, including dietitians and therapists, if they can afford to. Patients can get the prescription through their primary care doctor, too.

Many people find that the injections help them feel fuller longer and reduce sugary cravings. It “makes them crave protein and fiber more — thus helping them stick to diet changes that can further enhance their weight loss,” Duah said. Some people say it also reduced their desire to drink alcohol, and helped them to get better sleep.

Ozempic is approved for Type 2 diabetes, not obesity or weight loss, although people are getting it off-label for weight loss purposes. It’s entirely legal for doctors to prescribe meds off-label, but this is likely adding to ongoing drug shortages — which is a major issue for people with diabetes who can’t get hold of the medications.

Obesity doctors are excited that there’s finally a medication to help people, but there are some barriers and side effects to note.

What’s the overall take on these weight loss medications?

Obesity doctors are thrilled. Often, people retain weight because of health problems out of their control, not for lack of willpower or discipline. Many patients with obesity have tried it all, only to see minimal results. “Now we have something to help them,” Azagury said.

According to Duah, the recent surge in prescriptions, for the most part, is for good reason. “It is by far the most efficacious weight loss medication on the market, with users losing up to 20% of their starting body weight,” Duah said.

And even though interest in these drugs is soaring, Azagury thinks they can help still more people. The original class of obesity drugs from the 1960s and ’70s had nasty consequences and likely soured many people on the whole idea. It might take some convincing for more people to accept that there’s finally an effective drug for weight loss available, Azagury said.

There’s also the issue of cost. These drugs aren’t always covered by insurance, Azagury said, so it can get expensive (to the tune of $1,500 to $1,800 a month). “That is the biggest challenge people will face,” Azagury said. “It’s FDA-approved; that doesn’t mean insurance is going to pay for it.”

According to Duah, this is one of the main reasons providers end up prescribing Ozempic instead. Unlike Wegovy, Ozempic is often covered for diabetes or insulin resistance, so patients looking for semaglutide injections can get access to them at a reasonable price.

There are some risks associated with semaglutide injections

As with any drug, there are risks — but the injections are surprisingly well tolerated, Azagury said. The most common side effects are gastrointestinal issues, like nausea, vomiting, constipation, gas and heartburn. These GI-related side effects should subside as your body gets used to the injections; until then, they can mostly be handled by eating smaller, more frequent meals or taking over-the-counter medications like bismuth subsalicylate or heartburn relief tablets, Duah said. (If the side effects persist, be sure to talk to your doctor about finding relief or other, more tolerable options.)

In rare cases, semaglutide injections can lead to thyroid tumors, which can be cancerous. Other potential serious side effects include pancreatitis, gallbladder problems, low blood sugar, kidney issues, allergic reactions and depression. The injections also shouldn’t be used with other drugs that contain semaglutide or that target GLP-1 receptors.

We’re still learning about long-term side effects, since the drug is relatively new. The injections aren’t a quick fix, and most people will have to stay on the medications for at least a year (and likely longer) to meet their weight loss goals and improve their health, according to Azagury. One study found that many people who stop taking the medications rapidly gain the weight back, supporting the growing belief that the injections are meant to be taken for the long haul.

Other than a slightly higher risk of gallstones (which is common with many types of rapid weight loss), we haven’t seen any long-term effects with liraglutide, a similar drug that’s been on the market since 2010. Azagury expects the same will be true with semaglutide-based medications, given their similarity ― but, of course, time will tell.

If you’re interested in semaglutide injections, talk to your doctor. Understand the risks and benefits, and keep in mind that due to inflation, supply issues and growing demand, these drugs tend to be back-ordered — often for the people who need them most. Hopefully, supply will ramp up soon and more insurers will cover the cost. That, Duah said, will help more people get the drugs at a fair price.

“If insurances covered weight loss medications like Wegovy and supply was increased, we wouldn’t be seeing these issues with keeping Ozempic stocked on our pharmacies’ shelves,” Duah said.

fbq('init', '1621685564716533'); fbq('track', "PageView");

var _fbPartnerID = null; if (_fbPartnerID !== null) { fbq('init', _fbPartnerID + ''); fbq('track', "PageView"); }

(function () { 'use strict'; document.addEventListener('DOMContentLoaded', function () { document.body.addEventListener('click', function(event) { fbq('track', "Click"); }); }); })();

Read original article here

Common Food Additives Linked to an Increased Risk of Type 2 Diabetes

Foods that commonly use nitrite preservatives include processed meats such as bacon, ham, hot dogs, sausages, corned beef, and cured meats. Additionally, some cheeses, smoked fish, and pickled products may also contain nitrite preservatives.

A new study has found a link between consuming nitrites from drinking water and diet and the risk of developing type 2 diabetes. Nitrates and nitrates are naturally found in water and soil and are used as food preservatives to extend shelf life. The research was led by Bernard Srour and was published in the journal PLOS Medicine.

Some public health officials have suggested restricting nitrites and nitrates as food additives, however, their effect on metabolic issues and type 2 diabetes in humans is unexplored. To study the connection, researchers used data from 104,168 participants in the NutriNet-Santé prospective cohort.

The NutriNet-Santé study is an ongoing, web-based cohort study initiated in 2009. Participants aged fifteen and older enroll voluntarily and self-report medical history, sociodemographic, diet, lifestyle, and major health updates. The researchers used detailed nitrite/nitrate exposure, derived from several databases and sources, and then developed statistical models to analyze self-reported diet information with health outcomes.

The researchers found that participants in the NutriNet-Santé cohort reporting a higher intake of nitrites overall and specifically from food additives, and non-additive sources had a higher risk of developing type 2 diabetes. There was no association between nitrates and type 2 diabetes risk, and the findings did not support any potential benefits for dietary nitrites or nitrates in terms of protection against type 2 diabetes.

The study had several limitations and additional research is required to validate the results. The data were self-reported and the researchers could not confirm specific nitrite/nitrate exposure using biomarkers due to the underlying biological challenges. Additionally, people in the cohort’s demographics and behaviors may not be generalizable to the rest of the population – the cohort included a greater number of younger individuals, more often women, who exhibited healthier behaviors. Residual confounding may also have impacted the outcomes as a result of the observational design of the study.

According to the authors, “These results provide a new piece of evidence in the context of current discussions regarding the need for a reduction of nitrite additives’ use in processed meats by the food industry and could support the need for better regulation of soil contamination by fertilizers. In the meantime, several public health authorities worldwide already recommend citizens to limit their consumption of foods containing controversial additives, including sodium nitrite”.

Srour and Touvier add, “This is the first large-scale cohort study to suggest a direct association between additives-originated nitrites and type-2 diabetes risk. It also corroborates previously suggested associations between total dietary nitrites and T2D risk.”

Reference: “Dietary exposure to nitrites and nitrates in association with type 2 diabetes risk: Results from the NutriNet-Santé population-based cohort study” by Bernard Srour, Eloi Chazelas, Nathalie Druesne-Pecollo, Younes Esseddik, Fabien Szabo de Edelenyi, Cédric Agaësse, Alexandre De Sa, Rebecca Lutchia, Charlotte Debras, Laury Sellem, Inge Huybrechts, Chantal Julia, Emmanuelle Kesse-Guyot, Benjamin Allès, Pilar Galan, Serge Hercberg, Fabrice Pierre, Mélanie Deschasaux-Tanguy and Mathilde Touvier, 17 January 2023, PLOS Medicine.
DOI: 10.1371/journal.pmed.1004149



Read original article here

‘Ozempic face?’ Dr. Siegel warns of popular diabetes drug’s bizarre side effect

It’s the weight loss drug people have dreamed of  – or is it?

Diabetes drugs like semaglutide and tirzepatide have taken the medical community by storm, helping to not only keep certain endocrine disorders at bay, but also by showing promising signs of appetite control, improved insulin sensitivity, and, with both, weight loss. But the miraculous effects of the TikTok-famous Ozempic injections come at a cost.

“I spoke with some dermatologists about this yesterday,” Dr. Siegel said of “Ozempic face,” a bizarre side effect reported in Ozempic patients who claim the drug is making them look older. “It’s an overuse of the drug to where you lose weight too quickly. The buccal mucosa – the fat – leaves your face, and you become gaunt looking.”

OZEMPIC DIABETES DRUG IS TRENDING AS A WEIGHT-LOSS METHOD – HERE’S WHY AND WHAT DOCTORS SAY

Siegel warned Sunday on “Fox & Friends Weekend” that the side effect could possibly be irreversible.

Semaglutide injections have taken center stage amid the ever-lasting search for the immaculate weight loss solution.
(iStock)

“It’s something that happens to us anyway as we get older,” he explained.

OZEMPIC DRUG FACES SHORTAGE AFTER ENDORSEMENTS BY CELEBS

Reports of sagging skin, an older appearance and a “gaunt face” are now following the insanely popular “weight loss” injections, but Dr. Siegel still praised the drug for its potential to do great things.

“Ozempic is actually a great drug. It’s the first weight loss drug I’ve seen that I think really works,” he said. “It actually improves insulin, it improves getting rid of sugar, it decreases hunger…”

A diabetes patient prepares to administer an Ozempic injection in the stomach.
(iStock)

TikTok turned semaglutide injections like Ozempic into the latest weight loss craze for its alleged host of benefits, creating longstanding shortages and sparking debate surrounding whether patients should have off-label access to the drug.

Celebrities also took to the trend and spoke publicly about their use, creating an alarming recipe for ongoing shortages.

WEIGHT LOSS SECRETS FROM KIM KARDASHIAN, JESSICA SIMPSON AND MORE: EXPERT REVEALS WHAT NOT TO DO

Weight loss from diabetes drugs is becoming an increasingly common craze.
(Photo by Annette Riedl/picture alliance via Getty Images))

Since the popular drug became a namesake among the weight loss community, the FDA approved another stronger semaglutide injection and glucagon-like peptide agonist (GLP-1 agonist) for long-term weight loss named Wegovy.

The drug also saw shortages after demand skyrocketed last year.

In addition to concerns over “Ozempic face” and the older appearance it allegedly causes, experts have warned that the drugs can cause other, more serious side effects, including increased risk for rare forms of thyroid tumors, vision changes, kidney problems and gallbladder issues.

Rapid weight loss also poses health risks, potentially causing gallbladder issues, metabolic issues and hormonal imbalances.

Semaglutide and tirzepatide injections are also used to help treat or control other endocrine disorders such as insulin resistance or pre-diabetes and metabolic syndrome.

CLICK HERE TO GET THE FOX NEWS APP

Fox News’ Julia Musto contributed to this report.

Read original article here

Weight loss surgery extends lives, study finds



CNN
 — 

Weight loss surgery reduces the risk of premature death, especially from such obesity-related conditions as cancer, diabetes and heart disease, according to a new 40-year study of nearly 22,000 people who had bariatric surgery in Utah.

Compared with those of similar weight, people who underwent one of four types of weight loss surgery were 16% less likely to die from any cause, the study found. The drop in deaths from diseases triggered by obesity, such as heart disease, cancer and diabetes, was even more dramatic.

“Deaths from cardiovascular disease decreased by 29%, while deaths from various cancers decreased by 43%, which is pretty impressive,” said lead author Ted Adams, an adjunct associate professor in nutrition and integrative physiology at the University of Utah’s School of Medicine.

“There was also a huge percentage drop — a 72% decline — in deaths related to diabetes in people who had surgery compared to those who did not,” he said. One significant downside: The study also found younger people who had the surgery were at higher risk for suicide.

The study, published Wednesday in the journal Obesity, reinforces similar findings from earlier research, including a 10-year study in Sweden that found significant reductions in premature deaths, said Dr. Eduardo Grunvald, a professor of medicine and medical director of the weight management program at the University of California San Diego Health.

The Swedish study also found a significant number of people were in remission from diabetes at both two years and 10 years after surgery.

“This new research from Utah is more evidence that people who undergo these procedures have positive, beneficial long-term outcomes,” said Grunvald, who coauthored the American Gastroenterological Association’s new guidelines on obesity treatment.

The association strongly recommends patients with obesity use recently approved weight loss medications or surgery paired with lifestyle changes.

“And the key for patients is to know that changing your diet becomes more natural, more easy to do after you have bariatric surgery or take the new weight loss medications,” said Grunvald, who was not involved in the Utah study.

“While we don’t yet fully understand why, these interventions actually change the chemistry in your brain, making it much easier to change your diet afterwards.”

Despite the benefits though, only 2% of patients who are eligible for bariatric surgery ever get it, often due to the stigma about obesity, said Dr. Caroline Apovian, a professor of medicine at Harvard Medical School and codirector of the Center for Weight Management and Wellness at Brigham and Women’s Hospital in Boston. Apovian was the lead author for the Endocrine Society’s clinical practice guidelines for the pharmacological management of obesity.

Insurance carriers typically cover the cost of surgery for people over 18 with a body mass index of 40 or higher, or a BMI of 35 if the patient also has a related condition such as diabetes or high blood pressure, she said.

“I see patients with a BMI of 50, and invariably I will say, ‘You’re a candidate for everything — medication, diet, exercise and surgery.’ And many tell me, ‘Don’t talk to me about surgery. I don’t want it.’ They don’t want a surgical solution to what society has told them is a failure of willpower,” she said.

“We don’t torture people who have heart disease: ‘Oh, it’s because you ate all that fast food.’ We don’t torture people with diabetes: ‘Oh, it’s because you ate all that cake.’ We tell them they have a disease, and we treat it. Obesity is a disease, too, yet we torture people with obesity by telling them it’s their fault.”

Most of the people who choose bariatric surgery — around 80% — are women, Adams said. One of the strengths of the new study, he said, was the inclusion of men who had undergone the procedure.

“For all-causes of death, the mortality was reduced by 14% for females and by 21% for males,” Adams said. In addition, deaths from related causes, such as heart attack, cancer and diabetes, was 24% lower for females and 22% lower for males who underwent surgery compared with those who did not, he said.

Four types of surgery performed between 1982 and 2018 were examined in the study: gastric bypass, gastric banding, gastric sleeve and duodenal switch.

Gastric bypass, developed in the late 1960s, creates a small pouch near the top of the stomach. A part of the small intestine is brought up and attached to that point, bypassing most of the stomach and the duodenum, the first part of the small intestine.

In gastric banding, an elastic band that can be tightened or loosened is placed around the top portion of the stomach, thus restricting the volume of food entering the stomach cavity. Because gastric banding is not as successful in creating long-term weight loss, the procedure “is not as popular today,” Adams said.

“The gastric sleeve is a procedure where essentially about two-thirds of the stomach is removed laparoscopically,” he said. “It takes less time to perform, and food still passes through the much-smaller stomach. It’s become a very popular option.”

The duodenal switch is typically reserved for patients who have a high BMI, Adams added. It’s a complicated procedure that combines a sleeve gastrectomy with an intestinal bypass, and is effective for type 2 diabetes, according to the Cleveland Clinic.

One alarming finding of the new study was a 2.4% increase in deaths by suicide, primarily among people who had bariatric surgery between the ages of 18 and 34.

“That’s because they are told that life is going to be great after surgery or medication,” said Joann Hendelman, clinical director of the National Alliance for Eating Disorders, a nonprofit advocacy group.

“All you have to do is lose weight, and people are going to want to hang out with you, people will want to be your friend, and your anxiety and depression are going to be gone,” she said. “But that’s not reality.”

In addition, there are postoperative risks and side effects associated with bariatric surgery, such as nausea, vomiting, alcoholism, a potential failure to lose weight or even weight gain, said Susan Vibbert, an advocate at Project HEAL, which provides help for people struggling with eating disorders.

“How are we defining health in these scenarios? And is there another intervention — a weight neutral intervention?” Vibbert asked.

Past research has also shown an association between suicide risk and bariatric surgery, Grunvald said, but studies on the topic are not always able to determine a patient’s mental history.

“Did the person opt for surgery because they had some unrealistic expectations or underlying psychological disorders that were not resolved after the surgery? Or is this a direct effect somehow of bariatric surgery? We can’t answer that for sure,” he said.

Intensive presurgery counseling is typically required for all who undergo the procedure, but it may not be enough, Apovian said. She lost her first bariatric surgery patient to suicide.

“She was older, in her 40s. She had surgery and lost 150 pounds. And then she put herself in front of a bus and died because she had underlying bipolar disorder she had been self-medicating with food,” Apovian said. “We as a society use a lot of food to hide trauma. What we need in this country is more psychological counseling for everybody, not just for people who undergo bariatric surgery.”

Managing weight is a unique process for each person, a mixture of genetics, culture, environment, social stigma and personal health, experts say. There is no one solution for all.

“First, we as a society must consider obesity as a disease, as a biological problem, not as a moral failing,” Grunvald said. “That’s my first piece of advice.

“And if you believe your life is going to benefit from treatment, then consider evidence-based treatment, which studies show are surgery or medications, if you haven’t been able to successfully do it with lifestyle changes alone.”

Read original article here

Why Episodes of Low Blood Sugar Worsen Eye Disease in People With Diabetes

Summary: People with diabetes who experience low blood sugar are more likely to experience worsening diabetic retinopathy.

Source: Johns Hopkins Medicine

People with diabetes who experience periods of low blood sugar—a common occurrence in those new to blood sugar management—are more likely to have worsening diabetic eye disease.

Now, researchers at Johns Hopkins Medicine say they have linked such low blood sugar levels with a molecular pathway that is turned on in oxygen-starved cells in the eye.

The research, involving human and mouse eye cells and intact retinas grown in a low sugar (low glucose) environment in the laboratory, as well as mice with low glucose levels, was published in the January issue of Cell Reports.

“Temporary episodes of low glucose happen once or twice a day in people with insulin-dependent diabetes and often among people newly diagnosed with the condition,” says Akrit Sodhi, M.D., Ph.D., the Branna and Irving Sisenwein Professor of Ophthalmology at the Wilmer Eye Institute at Johns Hopkins Medicine.

Low glucose levels can also occur during sleep in people with non-insulin dependent diabetes. “Our results show that these periodic low glucose levels cause an increase in certain retinal cell proteins, resulting in an overgrowth of blood vessels and worsening diabetic eye disease,” adds Sodhi.

Eye disease among people with diabetes is among the most preventable causes of blindness in the U.S. Diabetic retinopathy, which occurs in up to a third of people with diabetes, is characterized by the overgrowth of abnormal blood vessels in the retina.

Sodhi says the current study suggests that people with diabetic retinopathy may be particularly vulnerable to periods of low glucose, and keeping glucose levels stable should be an important part of glucose control.

For the study, the researchers analyzed protein levels in human and mouse retinal cells and intact retinas grown in an environment of low glucose in the laboratory, as well as in mice that had occasional low blood sugar.

The researchers found that low glucose levels in human and mouse retinal cells caused a cascade of molecular changes that can lead to blood vessel overgrowth. First, the researchers saw that low glucose caused a decrease in retinal cells’ ability to break down glucose for energy.

When the researchers looked specifically at so-called Müller glial cells, which are supportive cells for neurons in the retina and rely primarily on glucose for energy production, they found that the cells increased the expression of the GLUT1 gene, which makes a protein that transports glucose into cells.

Low glucose levels can also occur during sleep in people with non-insulin dependent diabetes. Image is in the public domain

The researchers found that, in response to low glucose, the cells increased levels of a transcription factor, called hypoxia-inducible factor (HIF)-1α. This turned on the cellular machinery—including GLUT1—needed to improve their ability to utilize available glucose, preserving the limited oxygen available for energy production by retinal neurons.

However, in low-oxygen environments, as occurs in the retinas of patients with diabetic eye disease, this normal, physiologic response to low glucose triggered a flood of HIF-1α protein into the cells’ nucleus, the cell’s control center.

This resulted in an increase in the production of proteins such as VEGF and ANGPTL4, which cause the growth of abnormal, leaky blood vessels—the key culprit of vision loss in people with diabetic eye disease.

The researchers plan to study whether low glucose levels in people with diabetes may impact similar molecular pathways in other organs, such as the kidney and brain.

Sodhi says the HIF-1α pathway may serve as an effective target for developing new treatments for diabetic eye disease.

About this diabetes and visual neuroscience research news

Author: Press Office
Source: Johns Hopkins Medicine
Contact: Press Office – Johns Hopkins Medicine
Image: The image is in the public domain

See also

Original Research: Open access.
“HIF-1α accumulation in response to transient hypoglycemia may worsen diabetic eye disease” by Chuanyu Guo et al. Cell Reports


Abstract

HIF-1α accumulation in response to transient hypoglycemia may worsen diabetic eye disease

Highlights

  • Diabetic patients experience brief episodes of low glucose (hypoglycemia) each day
  • In retinal glial cells, hypoglycemia promotes the HIF-dependent expression of GLUT1
  • Hypoglycemia increases expression of HIF-dependent angiogenic mediators
  • This physiologic response causes paradoxical worsening of diabetic retinopathy

Summary

Tight glycemic control (TGC), the cornerstone of diabetic management, reduces the incidence and progression of diabetic microvascular disease. However, TGC can also lead to transient episodes of hypoglycemia, which have been associated with adverse outcomes in patients with diabetes.

Here, we demonstrate that low glucose levels result in hypoxia-inducible factor (HIF)-1-dependent expression of the glucose transporter, Glut1, in retinal cells.

Enhanced nuclear accumulation of HIF-1α was independent of its canonical post-translational stabilization but instead dependent on stimulation of its translation and nuclear localization. In the presence of hypoxia, this physiologic response to low glucose resulted in a marked increase in the secretion of the HIF-dependent vasoactive mediators that promote diabetic retinopathy.

Our results provide a molecular explanation for how early glucose control, as well as glycemic variability (i.e., oscillating serum glucose levels), contributes to diabetic eye disease. These observations have important implications for optimizing glucose management in patients with diabetes.

Read original article here

What Is Ozempic Face? Doctors Explain the Side Effect of the Diabetes Drug

man preparing Semaglutide Ozempic injection control blood sugar levels

Getty

Medications intended for type 2 diabetes and clinical obesity — like Ozempic, Wegovy and Mounjaro — are trending on social media as drugs for quick weight loss.

However, some have reported the drugs cause an aged appearance, a side effect that is dubbed “Ozempic face.” One of those people is Jennifer Berger, who told The New York Times that she used Mounjaro (tirzepatide) to lose weight following her pregnancy.

Mounjaro, at higher doses, has been proven to be highly effective for weight loss similar to Wegovy.

Berger explained that although using the drug — taken weekly by injection in the thigh, stomach or arm — allowed her to lose 20 lbs. and she loved her results, the 41-year-old said her face started to look very gaunt.

“I remember looking in the mirror, and it was almost like I didn’t even recognize myself,” she told the outlet. “My body looked great, but my face looked exhausted and old.”

Dr. Oren Tepper, a New York-based plastic surgeon, explained to the Times that it’s common for weight loss to deflate key areas of the face, which can result in a person looking more aged.

“When it comes to facial aging, fat is typically more friend than foe,” he said. “Weight loss may turn back your biological age, but it tends to turn your facial clock forward.”

RELATED: Are Ozempic and Wegovy Safe? All About the Diabetes and Obesity Drugs

RELATED: Remi Bader Says She ‘Gained Double the Weight Back’ After Stopping Weight-Loss Drug Ozempic

Dr. Paul Jarrod Frank, a dermatologist in New York, coined the term “Ozempic face” to describe this side effect, noting that it’s typically people in their 40s or 50s who are concerned about the sagging that occurs as a result of the weight loss in their face.

“I see it every day in my office,” Frank said. “A 50-year-old patient will come in, and suddenly, she’s super-skinny and needs filler, which she never needed before. I look at her and say, ‘How long have you been on Ozempic?’ And I’m right 100 percent of the time. It’s the drug of choice these days for the 1 percent.”

To restore volume in a patient’s face, doctors will often perform noninvasive, but expensive, procedures such as injecting Radiesse and hyaluronic acid-based fillers or Sculptra injections, which stimulates collagen production. Doctors can also restore volume with a face lift or by transferring fat from other body parts to the face.

Read original article here

Houston patients struggle to find Ozempic as popularity for weight loss drugs skyrockets across social media

HOUSTON – The drug Semaglutide was initially marketed under the name Ozempic to manage type two diabetes. Last year, Semaglutide was approved by the FDA to be used for weight loss under the name Wegovy.

Social media has nicknamed them “skinny pens” because they help people drop significant weight quickly, leading to the popularity and a shortage of both Ozempic and Wegovy.

The drug manufacturer Novo Nordisk confirms it’s struggling to meet demand and Houston patients, like Lauren Luman, say she doesn’t know what she’ll do.

“I reached out to my doctor again letting them know that I was still experiencing that shortage, at that time they were able to give me some more samples, but they said, ‘We’re not sure how long we’re going to continue to have the samples available,’” Luman said.

Ozempic helped Luman lose weight and control her blood sugar. Now, she says she’s getting the same answer at every pharmacy she visits.

“It’s been weeks or months since they’ve had any supply,” Luman said.

Endocrinologists have said they’re frustrated patients cannot find their medication. However, endocrinologist Dr. Disha Narang, suggests there’s a need for successful weight loss drugs on the market.

“Our nation is, you know, there’s an epidemic of obesity as well and we need to treat the obesity to prevent diabetes in the first place,” Dr. Narang said.

Doctors are not doing anything wrong by prescribing Ozempic for obesity. According to the FDA, healthcare professionals can choose to prescribe drugs off-label when medically appropriate.

“Its intended use is for it to be an anti-diabetic prescription,” Luman said. “So, if people are taking it just for the sake of weight loss, I feel like maybe they should step back and allow the people that have type two diabetes and really need it to lower their A1C the ability to get this prescription.”

According to one study, the weight loss may return once the patient discontinues use.

Copyright 2023 by KPRC Click2Houston – All rights reserved.

Read original article here

HIGH blood sugar management: 5 types of nuts that are good for people with diabetes – check complete list | Health News

If you have diabetes or high blood sugar, what cannot and can be eaten becomes a major topic of concern. Diet plays a significant role in controlling Type 2 diabetes and as Sumaiya A, Clinical Dietitian, Fortis Hospital, Kalyan, points out, one such beneficial food item for people with diabetes is nuts as they have many nutritional benefits. Nuts are high in monounsaturated and polyunsaturated fats, fibre, vitamins, minerals, and phytonutrients. The dietitian points out that when a diabetic person consumes nuts, they feel fuller. Due to this, when they have a proper meal, the consumption of the quantity of rice or chapati decreases, which in turn, helps in getting the sugar level under control.

High blood sugar: Why you should have THESE nuts

Sumaiya A lists the different types of nuts that are good for people with diabetes and why:

1) Almond: Consumption of this nut is especially good when it comes to glucose control in pre-diabetes. Almonds are high in many nutrients along with fiber, vitamin E, magnesium, and vitamin 12, so include them in snacks.

2) Pistachio: It has a low glycemic index and eating pistachios improves glycemic status in people having Type 2 diabetes. A Mediterranean diet rich in pistachios improves glucose levels, low-density lipoprotein cholesterol, and total cholesterol levels.

3) Walnut: It is a store house of omega 3 and is also used to make walnut oil. Walnut contains protein and polyunsaturated fats. Unsaturated fatty acids (monounsaturated fatty acids and polyunsaturated fatty acids) present in walnut may play a role in glucose control and also suppress your appetite by allevating hunger.

Also read: Lowering high blood sugar to making bones stronger: 7 amazing health benefits of drumsticks

4) Cashew nut: Cashew nut extract has anti-diabetic properties. And while fat content in cashews are relatively higher, most of this is good fat which is healthy for diabetes patients. When it comes to saturated, monosaturated, and polyunsaturated fat, cashews have an ideal fat ratio of 1:2:1. Regular consumption can lower bad cholesterol (LDL) and raise good cholesterol (HDL), which reduces risk of heart ailments. It also helps in lowering blood sugar levels.

5) Peanut: It is high in protein, fats and fibre, while at the same time has a low glycemic index; thus peanuts can reduce the spike in sugar levels.

While nuts are good for health, other health conditions should also be kept in mind and people should consult doctors in case they have problems like heart issues, cholesterol problems, hypertension etc. “All nuts should be consumed in moderate amount to control the sugar levels, and other health conditions,” Sumiaya adds.



Read original article here